Acute Effects of R- and S-MDMA in Healthy Subjects
Status:
Not yet recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
Racemic ±3,4-methylenedioxymethamphetamine (MDMA) is a psychoactive substance and
prototypical empathogen acutely inducing feelings of heightened mood, empathy, trust and
closeness to others. These acute subjective effects of MDMA may be helpful to assist
psychotherapy and MDMA is currently investigated in phase 3 trials as a possible treatment in
post-traumatic stress disorder.